In particular, TOX overexpression is a hallmark of poor prognosis in CTCL, although low level of TOX expression has been previously reported in benign dermatoses (31, 60). The gene discussed is TOX; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.